The expression of symptoms of viral infections is a byproduct of complex virus-host molecular pathways. These remain largely ...

Over the last several days, the safety and efficacy of messenger RNA, or mRNA, vaccines have come under intense scrutiny. On Tuesday, the U.S. Food and Drug Administration announced plans to limit ...

Maravai’s cash balance decreased to $285 million as of the end of the first quarter of 2025 from $322 million at the end of 2024. This decrease primarily stems from a free cash flow deficit of about ...

Researchers at the National University of Singapore (NUS) have developed a scalable, non-viral technology that efficiently ...

From my colleague Adam Feuerstein: French drug maker Sanofi is acquiring the small biotech Vigil Neuroscience for $470 ...